Acknowledgments
The author would like to thank staff of the Department of Urology in Sultan Abdulhamid Han Education and Research Hospital.
REFERENCES 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30.
2. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol.1995;154(5):1791-1794.
3. Cheville JC, Reznicek MJ, Bostwick DG. The focus of ”atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol.1997;108(6):633-640.
4. Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick DG, Montorsi F. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as ”atypical small acinar proliferation suspicious for but not diagnostic of malignancy”). Eur Urol. 2006;50(4):666-674.
5. Srirangam V, Rai BP, Abroaf A, et al. Atypical Small Acinar Proliferation and High Grade Prostatic Intraepithelial Neoplasia: Should We Be Concerned? An Observational Cohort Study with a Minimum Follow-Up of 3 Years. Curr Urol. 2017;10(4):199-205.
6. Leone L, Lacetera V, Montironi R, et al. Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy. Arch Ital Urol Androl. 2014;86(4):332-335.
7. Carroll PR, Parsons JK, Andriole G, et al. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.J Natl Compr Canc Netw. 2014;12(9):1211-1219; quiz 1219.
8. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618-629.
9. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175(3 Pt 1):820-834.
10. Ericson KJ, Wenger HC, Rosen AM, et al. Prostate cancer detection following diagnosis of atypical small acinar proliferation. Can J Urol. 2017;24(2):8714-8720.
11. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol. 2013;189(3):867-870.
12. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876-892.
13. Quaresima L, Lacetera V, Leone L, et al. The impact of repeated prostate biopsies on sexual function and urinary symptoms in patients with diagnosis of Atypical Small Acinar Proliferation (ASAP): can ecoDoppler reduce side effects? Arch Ital Urol Androl.2014;86(4):356-358.
14. Fandella A. Analysis of costs of transrectal prostate biopsy.Urologia. 2011;78(4):288-292.
15. Ynalvez LA, Kosarek CD, Kerr PS, et al. Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm. Int Urol Nephrol. 2018;50(1):1-6.
16. Leone A, Rotker K, Butler C, et al. Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer. Prostate Cancer. 2015;2015:810159.
17. Leone A, Gershman B, Rotker K, et al. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis.2016;19(1):68-71.
18. Mallen E, Gil P, Sancho C, et al. Atypical small acinar proliferation: review of a series of 64 patients. Scand J Urol Nephrol. 2006;40(4):272-275.
19. Sakura M, Kawakami S, Ishioka J, et al. A novel repeat biopsy nomogram based on three-dimensional extended biopsy. Urology.2011;77(4):915-920.
20. Moussa AS, Jones JS, Yu C, Fareed K, Kattan MW. Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling. BJU Int. 2010;106(9):1309-1314.
21. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol. 2005;173(2):421-424.
22. Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol. 2003;170(4 Pt 1):1184-1188; discussion 1188.
23. Scattoni V, Roscigno M, Freschi M, et al. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl.2005;77(1):31-36.
24. Chen R, Huang Y, Cai X, et al. Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml. PLoS One.2015;10(6):e0130308.